Media Center
Bringing together industry, the research community, government and economic diplomacy represents one of Slovenia’s greatest opportunities to strengthen the international position of its biotechnology and pharmaceutical ecosystem. This was the central theme of the meeting we organised on 1 September on the sidelines of the Bled Strategic Forum, for the second consecutive year.
More
At its 2nd annual meeting of members, partners, and supporters held last weekend in Bled, Slovenia Biotech Hills publicly launched its document “Strategic Guidelines for the Development of Biotechnology and Pharmaceuticals in Slovenia 2026–2035.”
More
More than 3,600 participants from around the world open new opportunities for Slovenia’s breakthrough pharmaceutical and biotechnology industries
More
Today marks an important milestone for the Slovenia Biotech Hills Institute.
MoreIn today’s pharmaceutical industry, it is increasingly clear that time is the most valuable currency. “Time-to-market” is becoming a key indicator of competitive advantage, as companies face growing pressure to develop therapies for increasingly complex medical needs. In an environment where the average development of a new drug takes more than a decade and requires multi-billion investments, every process optimization has a direct impact not only on business performance but also on patient health worldwide.
More
The European Commission has established a new center for biotechnology and biomanufacturing with the aim of supporting companies in introducing their innovative products to the EU market and increasing their competitiveness. The Biotechnology and Biomanufacturing Hub is a key outcome of the Commission’s strategy to promote biotechnology and biomanufacturing in the EU.
More